An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation

Journal of Perinatology

Volumn 32, Issue 9, 2012, Pages 660-664

  Maisels, M J ^a   Watchko, J F ^b   Bhutani, V K ^c   Stevenson, D K ^c  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

exchange transfusion; hyperbilirubinemia; jaundice; phototherapy

Indexed keywords

BILIRUBIN; BILIRUBIN GLUCURONIDE; IMMUNOGLOBULIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL EFFECTIVENESS; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; EXCHANGE BLOOD TRANSFUSION; FOLLOW UP; GESTATIONAL AGE; HEMOLYTIC ANEMIA; HUMAN; HYPERBILIRUBINEMIA; INFANT; INFANT MORTALITY; KERNICTERUS; LONG TERM CARE; NEWBORN INTENSIVE CARE; PHOTOTHERAPY; PREMATURITY;

BILIRUBIN; EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PHOTOTHERAPY;

EID: 84865738694     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2012.71     Document Type: Article

References (58)

1. American Academy of Pediatrics. Subcommittee on hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
2. van Imhoff DE, Dijk PH, Hulzebos CV, BARTrial Study Group, Netherlands Neonatal Research Network. Uniform treatment thresholds for hyperbilirubinemia in preterm infants: background and synopsis of a national guideline. Early Hum Dev 2011; 87: 521-525.
3. Kaplan M, Merlob P, Regev R. Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol 2008; 28: 389-397. (Pubitemid 351780931)
4. Rennie J, Burman-Roy S, Murphy MS. Neonatal jaundice: summary of NICE guidance. BMJ 2010; 340: 1190-1192.
5. Bratlid D, Nakstad B, Hansen TWR. National guidelines for treatment of jaundice in the newborn. Acta Paediatr 2011; 100(4): 499-505.
6. Canadian Paediatric Society. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation)-summary. Paediatr Child Health 2007; 12: 401-418.
7. Horn AR, Kirsten GF, Kroon SM, Henning PA, Moller G, Pieper C et al. Phototherapy and exchange transfusion for neonatal hyperbilirubinaemia. S Afr Med J 2006; 96: 819-824.
8. Maisels MJ, Watchko JF. Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2003; 88: F459-F463. (Pubitemid 37449417)
9. Rennie JM, Sehgal A, De A, Kendall GS, Cole TJ. Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia. Arch Dis Child Fetal Neonatol Ed 2009; 94: F323-F327.
10. Hansen TWR. Therapeutic approaches to neonatal jaundice: an international survey. Clin Pediatr 1996; 35: 309-316. (Pubitemid 26177176)
11. National Institute for Health and Clinical Excellence. Neonatal Jaundice. National Institute for Health and Clinical Excellence, 2010, www.nice.org.uk/CG98.
12. Bhutani VK. Survey of neonatologists in the Perinatal Section of the AAP (personal communication). 2011.
13. Watchko JF, Maisels MJ. Jaundice in low birth weight infants-pathobiology and outcome. Arch Dis Child Fetal Neonatol Ed 2003; 88: F455-F459.
14. Watchko JF, Oski FA. Kernicterus in preterm newborns: past, present and future. Pediatrics 1992; 90: 707-715.
15. Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonat Med 2010; 15: 157-163.
16. Keenan WJ, Perlstein PH, Light IJ, Sutherland JM. kernicterus in small, sick, premature infants receiving phototherapy. Pediatrics 1972; 49: 652-655.
17. Lipsitz PJ, Gartner LM, Bryla DA. Neonatal and infant mortality in relation to phototherapy. Pediatrics 1985; 75: 422-426. (Pubitemid 15172373)
18. Govaert P, Lequin M, Swarte R, Robben S, De Coo R, Weisglas-Kuperus N et al. Changes in globus pallidus with (pre) term kernicterus. Pediatrics 2003; 112: 1256-1263. (Pubitemid 37523404)
19. Moll M, Goelz R, Naegele T, Wilke M, Poets CF. Are recommended phototherapy thresholds safe enough for extremely low birth weight (ELBW) infants? A report on 2 ELBW infants with kernicterus despite only moderate hyperbilirubinemia. Neonatology 2011; 99: 90-94.
20. Sugama S, Soeda A, Eto Y. Magnetic resonance imaging in three children with kernicterus. Pediatr Neurol 2001; 25: 328-331. (Pubitemid 33026496)
21. Mazeiras G, Roze J-C, Ancel P-Y, Caillaux G, Frondas-Chauty A, Denizot S et al. Hyperbilirubinemia and neurodevelopmental outcome of very low birthweight infants: results from the LIFT cohort. PLoS ONE 2012; 7(1): 1-8.
22. Oh W, Tyson JE, Fanaroff AA, Vohr BR, Perritt R, Stoll BJ et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 2003; 112: 773-779. (Pubitemid 37248682)
23. O'Shea TM, Dillard RG, Klinepeter KL, Goldstein DJ. Serum bilirubin levels, intracranial hemorrhage, and the risk of developmental problems in very low birth weight infants. Pediatrics 1992; 90: 888-892.
24. Yeo KL, Perlman M, Hao Y, Mullaney P. Outcomes of extremely premature infants related to their peak serum bilirubin concentrations and exposure to phototherapy. Pediatrics 1998; 102(6): 1426-1431. (Pubitemid 28550837)
25. Morris BH, Oh W, Tyson JE, Stevenson D, Phelps DL, O'Shea TM et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. New Engl J Med 2008; 359: 1885-1896.
26. Brodersen R. Binding of bilirubin to albumin. CRC Crit Rev Clin Lab Sci 1980; 11: 305-399.
27. McDonagh AF, Maisels MJ. Bilirubin unbound: deja vu all over again? Pediatrics 2006; 117: 523-525. (Pubitemid 46071616)
28. Wennberg RP, Ahlfors CE, Bhutani V, Johnson LH, Shapiro SM. Toward understanding kernicterus: A challenge to improve the management of jaundiced newborns. Pediatrics 2006; 117: 474-485. (Pubitemid 46071611)
29. Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low birthweight infants. Pediatrics 1982; 69: 481-485. (Pubitemid 12135952)
30. Nakamura H, Yonetani M, Uetani Y, Funato M, Lee Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birth weight infants. Acta Paediatr Jpn 1992; 54: 642-647. (Pubitemid 23029101)
31. Oh W, Stevenson DK, Tyson JE, Morris BH, Ahlfors CE, Bender GJ et al. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatr 2010; 99: 673-678.
32. Ahlfors CE. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 1994; 93: 488-494. (Pubitemid 24067025)
33. Watchko JF. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. NeuroMolecular Med 2006; 8: 513-529.
34. Wennberg RP. Cellular basis of bilirubin toxicity. NY State J Med 1991; 91: 493-496.
35. Steiner LA, Bizzarro MJ, Ehrenkranz RA, Gallagher PG. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrcs 2007; 120: 27-32. (Pubitemid 47036237)
36. Maisels MJ. Phototherapy-traditional and nontraditional. J Perinatol 2001; 21: S93-S97.
37. Bryla DA, Brown A, Gartner L, Lipsitz P. Phototherapy for neonatal hyperbilirubinemia. Pediatrics 1986; 78(1): 180-181.
38. Tozzi E, Tozzi-Ciancarelli MG, Di Giulio A, D'Alfonso A, Farello G, Spennati GF et al. In vitro and in vivo effects of erythrocyte phototherapy in newborns. Biol Neonate 1989; 56(4): 204-209. (Pubitemid 19247330)
39. Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin Perinatol 2004; 28: 326-333. (Pubitemid 39626114)
40. Vreman HJ, Knauer Y, Wong RJ, Chan M-L, Stevenson DK. Dermal carbon monoxide excretion in neonatal rats during light exposure. Pediatr Res 2009; 66: 66-69.
41. Zuniga-Gonzalez G, Gomez-Meda BC, Lemus-Varela M, Zamora-Perez AL, Armendariz-Borunda J, Barros-Hernandez A et al. Micronucleated erythrocytes in preterm newborns exposed to phototherapy and/or oxygentherapy. Photochem Photobiol 2012; 107: 79-83.
42. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008; 358: 920-928. (Pubitemid 351397091)
43. Bhutani VK, Committee on Fetus and Newborn. Technical Report: phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2011; 128: e1046-e1052.
44. Watchko JF. Exchange transfusion in the management of neonatal hyperbilirubinemia In: Maisels MJ, Watchko JF (eds). Neonatal Jaundice 2000, pp 169-176.
45. Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 1997; 99: e7.
46. Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990 s. J Pediatr 2004; 144: 626-631. (Pubitemid 38594764)
47. Bowman JM. RhD hemolytic disease of the newborn. New Engl J Med 1998; 339: 1775-1777.
48. Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics (Suppl) 1985; 75: 417-421. (Pubitemid 15172372)
49. Grobler JM, Mercer MJ. Kernicterus associated with elevated predominantly directreacting bilirubin. S Afr Med J 1997; 87: 146.
50. Clark CF, Torii S, Hamamoto Y, Kaito H. The 'bronze baby' syndrome: postmortem data. J Pediatr 1976; 88: 461-464.
51. Ebbesen F. Low reserve albumin for binding of bilirubin in neonates with deficiency of bilirubin excretion and bronze baby syndrome. Acta Paediatr Scand 1982; 71: 415-420. (Pubitemid 12150284)
52. Bertini G, Dani C, Fonda C, Zorzi C, Rubaltelli F. Bronze baby syndrome and the risk of kernicterus. Acta Paediatr 2005; 94: 968-971. (Pubitemid 41044786)
53. Rü bo J, Albrecht K, Lasch P, Laufkötter E, Leititis J, Marsan D et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 1992; 121: 93-97.
54. Sato K, Hara T, Kondo T, Iwao H, Honda S, Ueda K. High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility. Acta Paediatr Scand 1991; 80: 163-166.
55. Alpay F, Sarici SÜ , Okutan V, Erdem G, Ö zcan O, Gökçay E. High-dose intravenous immunoglobin therapy in neonatal immune haemolytic jaundice. Acta Paediatr 1999; 88: 216-219. (Pubitemid 29124328)
56. Smits-Wintjens VEHJ, Walther FJ, Rath MEA, Lindenburg ITM, te Pas AB, Kramer CM et al. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: A randomized controlled trial. Pediatrics 2011; 127: 680-686.
57. Hammerman C, Kaplan M, Vreman HJ, Stevenson DK. Intravenous immune globulin in neonatal ABO isoimmunization: factors associated with clinical efficacy. Biol Neonate 1996; 70: 69-74. (Pubitemid 26270975)
58. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd edn. Little, Brown and Co: Boston, 1991.